S&P Stock Picks and Pans: Celgene, Autodesk, AstraZeneca
Analysts' opinions on stocks in the news
S&P REITERATES BUY OPINION ON SHARES OF CELGENE (CELG; 48.44):
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.